Format

Send to

Choose Destination
Congenit Heart Dis. 2010 May-Jun;5(3):303-8. doi: 10.1111/j.1747-0803.2009.00344.x.

Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.

Author information

1
Department of Pediatrics, Hematology-Oncology Section, Baylor College of Medicine, Houston, TX 77030, USA. lbomgaars@txccc.org

Abstract

Factor V and thrombin inhibitors may develop following exposure to bovine thrombin preparations. In patient populations where exposure to bovine thrombin is common, such as children undergoing cardiovascular surgery, the development of such inhibitors should be considered in the evaluation of prolonged prothrombin times. We present three cases of children developing factor V and thrombin inhibitors following repeated exposure during cardiac surgical procedures.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center